Clinical trial for Type 1 Diabetes
Official title Effects of Circadian Rhythm on Glycemic Regulation During Continuous Moderate Exercise and Intense Intermittent Disease in Adolescents Living With Type 1 Diabetes
ClinicalTrials.gov ID: NCT06803446
What this study is testing
- What it's testing
- Interventional research with minimal risks and constraints on the effects of circadian rhythm on glycemic regulation during intense moderate, continuous and intermittent exercise in adolescents living with type 1 diabetes
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 10 to 16
You may be able to join if
- Children and adolescents aged 10 to 16;
- Living with type 1 diabetes for at least 1 year with HbA1c less than or equal to 12%;
- Socially insured ;
- Having given their written consent to participate in the research, as well as that of their legal guardians;
- Willing to comply with all research procedures and duration.
You likely can't join if
- Clinically significant microvascular complications: nephropathy (estimated glomerular filtration rate less than 40 ml/min), neuropathy or severe...
- Recent acute macrovascular event (\< 3 months), e.g. acute coronary syndrome or cardiac surgery;
- Abnormal blood picture and/or anemia;
- Current pregnancy;
- Other serious medical condition likely to interfere with study participation or ability to complete exercise periods in the judgment of the...
- Inability to receive informed information;
See the full eligibility criteria
- Children and adolescents aged 10 to 16;
- Living with type 1 diabetes for at least 1 year with HbA1c less than or equal to 12%;
- Socially insured ;
- Having given their written consent to participate in the research, as well as that of their legal guardians;
- Willing to comply with all research procedures and duration.
- Clinically significant microvascular complications: nephropathy (estimated glomerular filtration rate less than 40 ml/min), neuropathy or severe proliferative retinopathy as assessed by the investigator;
- Recent acute macrovascular event (\< 3 months), e.g. acute coronary syndrome or cardiac surgery;
- Abnormal blood picture and/or anemia;
- Current pregnancy;
- Other serious medical condition likely to interfere with study participation or ability to complete exercise periods in the judgment of the investigator (e.g., orthopedic limitation);
- Inability to receive informed information;
- Inability to participate in the entire study;
- Lack of social security coverage;
- Refusal to sign the consent form.
The study team makes the final eligibility decision.
Where it's taking place
- Loos, Nord, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 10 years to 16 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Loos, Nord, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.